By analyzing human tissue samples and cellular models, we found that higher SMAD4 expression correlates with early-stage OSCC and epithelial markers, while decreased SMAD4 is associated with increased mesenchymal markers and tumor invasiveness. Here, SMAD4 is linked to neoplasm.